More
    Guided Solutions - Connecting Talent With Innovation/div>

    CathVision closes $7.2M financing round for electrophysiology recording tech

    Electrophysiology (EP) technology developer CathVision announced that it secured $7.2 million in funding from existing investors. Copenhagen, Denmark-based CathVision plans to use the funds to advance commercial operations for driving the adoption of its ECGenius system...

    CathVision closes $7.2M financing round for electrophysiology recording tech

    Electrophysiology (EP) technology developer CathVision announced that it secured $7.2 million in funding from existing investors. Copenhagen, Denmark-based CathVision plans to use the funds to advance...

    GN launches new technology platform to address the No.1 hearing aid challenge: hearing speech in noise

    ReSound OMNIA is made for hearing in noisy environments with an outstanding 150% improvement in speech understandingIntroducing enhanced ‘own voice’ perception, ReSound OMNIA hearing...

    FDA clears VySpine’s VyPlate anterior cervical plate system

    VySpine this week announced it received FDA 510(k) clearance for its VyPlate anterior cervical plate system. Tallahassee, Florida-based VySpine designed VyPlate to stabilize the anterior cervical...

    BD, Accelerate Diagnostics Announce Global Commercial Collaboration

    BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Accelerate Diagnostics, Inc. (NASDAQ: AXDX) an innovator of rapid in-vitro diagnostics in...
    [hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

    Finance

    Funding

    Clinical Trials

    OSSIO Announces U.S. Launch and First Commercial Use of OSSIOfiber® Suture Anchors, Expanding Patient Access to Growing Portfolio of Bio-Integrative Orthopedic Fixation Technology

    Indications for Use Include Surgery on Foot/Ankle, Shoulder, Knee, Hand/Wrist and Elbow Advantages Over Traditional Anchors Include Self-Tapping Insertion Strength, Superior Pull-Out Resistance, and Proven Bio-Integration Performance OSSIO, Inc.,...

    ŌNŌCOR announces endovascular retrieval system’s first-in-human use

    The ŌNŌ endovascular retrieval system is compatible with endovascular snares, vascular sheaths and other graspers. ŌNŌCOR has announced the first-in-human use of the catheter-based ŌNŌ endovascular retrieval...

    Randomized controlled study finds that monitoring brain function with Masimo SedLine ® can help control anesthesia in children undergoing minor surgery

    Anesthesiologists used less sevoflurane to maintain adequate anesthesia in children monitored with Masimo SedLine Masimo announced the results of a randomized controlled study...

    MolecuLight’s Fluorescence Imaging Device Improves Healing of Diabetic Foot Ulcers

    Medical imaging company MolecuLight reported results from a recent independent clinical trial that evaluated the use of their fluorescence imaging device MolecuLight i:X to detect elevated bacterial loads...
    1,663FollowersFollow

    Innovation

    Regulatory Approvals

    CathVision closes $7.2M financing round for electrophysiology recording tech

    Electrophysiology (EP) technology developer CathVision announced that it secured $7.2 million in funding from existing investors. Copenhagen, Denmark-based CathVision plans to use the funds to advance...

    GN launches new technology platform to address the No.1 hearing aid challenge: hearing speech in noise

    ReSound OMNIA is made for hearing in noisy environments with an outstanding 150% improvement in speech understandingIntroducing enhanced ‘own voice’ perception, ReSound OMNIA hearing...

    FDA clears VySpine’s VyPlate anterior cervical plate system

    VySpine this week announced it received FDA 510(k) clearance for its VyPlate anterior cervical plate system. Tallahassee, Florida-based VySpine designed VyPlate to stabilize the anterior cervical...

    BD, Accelerate Diagnostics Announce Global Commercial Collaboration

    BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Accelerate Diagnostics, Inc. (NASDAQ: AXDX) an innovator of rapid in-vitro diagnostics in...

    M&A

    Archives

    Latest articles